Brain Monitoring Market Size, Share & Industry Analysis, By Technology (Electrical Brain Activity Monitoring, Cerebral Oxygenation Monitoring, Intracranial Pressure Monitoring, and Others), By Procedure (Invasive and Non-invasive), By Application (Epilepsy & Seizure Monitoring, Neurocritical Care & Traumatic Brain Injury, Stroke & Cerebrovascular Monitoring, and Others), By End-user (Hospitals & Clinics, Diagnostics Laboratories, and Others), and Regional Forecast, 2026-2034

The global brain monitoring market size was valued at USD 4.88 billion in 2025. The market is projected to grow from USD 5.19 billion in 2026 to USD 8.94 billion by 2034, exhibiting a CAGR of 7.0% during the forecast period.

Brain monitoring is the adoption of simple tools that are used by healthcare professionals in order to track brain activity and brain functions. These devices are capable of detecting and analyzing stress signals. Moreover, it is used most in hospitals when patients are very sick, unconscious, sedated, or have had a head injury, stroke, or seizures. The market growth is largely fueled by the continuous improvements in brain monitoring technologies, the increasing incidence of neurological conditions, and the rising preference for minimally invasive monitoring solutions. Moreover, rising emphasis of the people on preventive care is also projected to accelerate market growth during the forecast period.

• For instance, in May 2025, Epsilon Medical Inc. received FDA approval for its EP-01 endovascular EEG device. The new device has been developed for monitoring and recording of brain electrical signals for epilepsy treatment.

Furthermore, many key industry players, such as Medtronic plc, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Nihon Kohden Corporation, and Natus Medical Incorporated, operating in the market, are focusing on developing various innovative technologies to offer better products with improved accuracy and efficiency.

BRAIN MONITORING MARKET TRENDS

Rising Preference for AI-based Devices and Simplified Setups is a Prominent Trend Observed in the Market

A major trend currently observed in the market is a growing preference for AI-based devices along with simplified setups. There is considerable demand for lightweight, user-friendly headbands and skin patches equipped with wireless EEG, which are becoming increasingly popular across clinical and consumer health applications. In addition, technological advancements in artificial intelligence are leading to the introduction of new devices with superior capabilities.

• For instance, in October 2024, Ceribell presented its multiple clinical study results at the Neurocritical Care Society Annual Meeting, showing that its rapid, bedside EEG system supported earlier seizure detection in critical care settings.

Download Free sample to learn more about this report.

MARKET DYNAMICS

MARKET DRIVERS

Technological Advancements in Brain Sensors and Growing Demand for Advanced Monitoring Tools to Accelerate Market Growth

Recent advancements in brain sensor miniaturization, wireless data transmission, and biocompatible materials are playing a vital role in the global brain monitoring market growth. These technological updates are enabling improved longevity, accuracy, and overall output of brain monitoring. Coupled with this, the rising demand for advanced monitoring tools for better disease analysis and research applications is also expected to have a positive impact on the market.

• For instance, in February 2022, Masimo received FDA approval for its SedLine brain function monitoring, which is specifically designed for pediatric patients.

MARKET RESTRAINTS

Limited Access to Trained Staff and Specialists to Hamper Market Growth

Limited access to trained staff is one of the critical factors impacting the growth of the market. There are still many brain monitoring methods that are highly dependent on specialist interpretation or trained technicians. Moreover, even when devices are available, hospitals may struggle with staffing and consistent use across departments. This slows adoption outside large centers and creates uneven access between urban and rural facilities. To reduce this gap, companies are introducing easier set-up systems and remote reading models.

MARKET OPPORTUNITIES

Rising Focus on Home-based or Bedside Brain Monitoring to Offer Lucrative Market Growth Opportunities

The global brain monitoring market is witnessing growing emphasis on home-based or bedside brain monitoring for better patient care and convenience. Moreover, there is substantial expansion for rapid bedside brain monitoring into more emergency rooms, ICUs, and smaller hospitals that currently rely on slower or limited options. Hospitals want tools that can be applied quickly, give usable signals, and help decide next steps without waiting too long.

• For instance, in April 2024, NeuroVigil is developing a personal brain monitor, iBrain, in order to measure the brain’s electrical activity in people with neurological conditions.

MARKET CHALLENGES

Limited Awareness Outside Specialist Departments to Pose a Critical Challenge to Market Growth

One challenge to market growth is limited awareness outside neurology-focused departments. In many hospitals, brain monitoring is mainly associated with neurologists or neuro ICUs, and other departments may not consider it as part of routine care. Emergency physicians, intensivists, or surgical teams may rely on traditional observation methods instead. As a result, brain monitoring devices may be underused even when available.

Segmentation Analysis

By Technology

Considerable Adoption of Consumables Due to Repetitive Testing to Boost Segmental Growth

Based on the technology, the market is divided into electrical brain activity monitoring, cerebral oxygenation monitoring, intracranial pressure monitoring, and others.

The electrical brain activity monitoring segment is anticipated to account for the largest brain monitoring market share. In this type of technology, there is high use of EEG-based monitoring. As EEG-based monitoring is considerably preferred and performed for seizures, ICU monitoring, and brain function checks during sedation, the segment holds a substantial market share. In addition, technological advancements in EEG are also projected to boost segment growth.

• For instance, in October 2025, Samsung announced the development of its ear-based EEG devices, which enable the real-time monitoring of brain activities.

The cerebral oxygenation monitoring segment is anticipated to rise with a CAGR of 7.8% over the forecast period.  

To know how our report can help streamline your business, Speak to Analyst

By Procedure

Higher Emphasis on Minimally Invasive Diagnostics to Accelerate Non-invasive Segment Growth

Based on the procedure, the market is segmented into non-invasive and invasive.

In 2025, the non-invasive segment dominated the global market. The segment growth is majorly attributed to the increasing global emphasis on remote monitoring and minimally invasive diagnostics. In addition, emphasis on market players for technological developments is further expected to boost segment growth during the forecast period.

• For instance, in June 2025, iMotions announced a strategic partnership with Artinis Medical Systems for the development of a new product with integrated technologies.

By Application

Continual Requirement of Monitoring for Neurocritical Care and Traumatic Brain Injury to Boost Segment Growth

Based on application, the market is segmented into epilepsy & seizure monitoring, neurocritical care & traumatic brain injury, stroke & cerebrovascular monitoring, and others.

In 2025, the neurocritical care and traumatic brain injury segment dominated the global market. Neurocritical care and traumatic brain injury hold a high share because these conditions require continuous brain observation, not just a one-time assessment. In addition, TBI patients can deteriorate suddenly due to swelling, bleeding, or seizures, even after initial stabilization. Brain monitoring helps clinicians watch for early warning signs when patients cannot communicate their symptoms. Further, road accidents, falls, and trauma keep TBI case volumes high globally, especially in emergency departments. In neuro ICUs, monitoring supports treatment decisions and recovery tracking.

The stroke & cerebrovascular monitoring segment is projected to grow at a CAGR of 7.5% over the forecast period. 

By End-User

Availability of Advanced Resources in Hospitals & Clinics to Accelerate Segment Growth

Based on end-user, the market is segmented into hospitals & clinics, diagnostics laboratories, and others.

The hospitals & clinics dominated the global market. Hospitals and clinics account for the largest share because brain monitoring is mainly needed in acute and critical care settings. Emergency departments, ICUs, and surgical units are where patients with head injury, seizures, or altered consciousness are treated. These facilities have the necessary staff, monitoring infrastructure, and patient volumes. Furthermore, the segment is set to hold a 70.7% share in 2026.

In addition, diagnostics laboratories are projected to grow at a CAGR of 7.0% during the study period.

Brain Monitoring Market Regional Outlook

By region, the market is categorized into Europe, North America, Asia Pacific, Latin America, and the Middle East & Africa.

North America

To get more information on the regional analysis of this market, Download Free sample

North America held the dominant share in 2024, valued at USD 1.74 billion, and also maintained the leading share in 2025, with USD 1.85 billion. The market in North America is expected to increase due to technological advancements, considerable prevalence of neurological conditions, and growing product approvals.

U.S Brain Monitoring Market

Based on North America’s strong contribution and the U.S. dominance within the region, the U.S. market can be analytically approximated at around USD 1.67 billion in 2026, accounting for roughly 32.2% of global brain monitoring sales.

Europe

Europe is projected to record a growth rate of 6.5% in the coming years, which is the second highest among all regions, and reach a valuation of USD 1.46 billion by 2026. The region is estimated to witness considerable market growth due to rising emphasis on preventive care and technological advancements in brain monitoring.

U.K Brain Monitoring Market

The U.K. brain monitoring market in 2026 is estimated at around USD 0.24 billion, representing roughly 4.6% of global brain monitoring revenues.

Germany Brain Monitoring Market

Germany’s brain monitoring market is projected to reach approximately USD 0.33 billion in 2026, equivalent to around 6.4% of global brain monitoring sales.

Asia Pacific

Asia Pacific is estimated to reach USD 1.26 billion in 2026 and secure the position of the third-largest region in the market. In the region, India and China are both estimated to reach USD 0.28 billion and USD 0.42 billion, respectively, in 2026.

Japan Brain Monitoring Market

The Japan brain monitoring market in 2026 is estimated at around USD 0.22 billion, accounting for roughly 4.2% of global brain monitoring revenues.

China Brain Monitoring Market

China’s brain monitoring market is projected to be one of the largest worldwide, with 2026 revenues estimated at around USD 0.42 billion, representing roughly 8.1% of global brain monitoring sales.

India Brain Monitoring Market

The Indian brain monitoring market in 2026 is estimated at around USD 0.28 billion, accounting for roughly 5.4% of global brain monitoring revenues.

Latin America and the Middle East & Africa

The Latin America and Middle East & Africa regions are expected to witness moderate growth in this market space during the forecast period. The Latin America market is set to reach a valuation of USD 0.33 billion in 2026. In the Middle East & Africa, the GCC is set to reach USD 0.07 billion in 2026.

South Africa Brain Monitoring Market

The South African brain monitoring market is projected to reach around USD 0.03 billion in 2026, representing roughly 0.54% of global brain monitoring revenues.

COMPETITIVE LANDSCAPE

Key Industry Players

Rising Emphasis on the Introduction of New Products by Key Players to Boost Market Progress

The global brain monitoring market holds a semi-consolidated market structure, constituting prominent players such as Medtronic plc, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Nihon Kohden Corporation, Natus Medical Incorporated, and Masimo Corporation. The significant global brain monitoring market share of these companies is due to numerous strategic activities, including collaboration among operating entities to advance research activities.

• For instance, in October 2025, Medtronic received the TIME Best Invention Award for its adaptive deep-brain stimulation system.

Other notable players in the global market include Edwards Lifesciences Corporation, Integra LifeSciences Holdings Corporation, Advanced Brain Monitoring, Inc., Compumedics Limited, Neurosoft LLC, and Micromed S.p.A. These companies are expected to prioritize new product launches and collaborations to increase their global market share during the forecast period.

LIST OF KEY BRAIN MONITORING COMPANIES PROFILED

• Medtronic plc (Ireland)
• Koninklijke Philips N.V. (Netherlands)
• GE HealthCare Technologies Inc. (U.S.)
• Nihon Kohden Corporation (Japan)
• Natus Medical Incorporated (U.S.)
• Edwards Lifesciences Corporation (U.S.)
• Integra LifeSciences Holdings Corporation (U.S.)
• Advanced Brain Monitoring, Inc. (U.S.)
• Compumedics Limited (Australia)
• Neurosoft LLC (Russia)
• Micromed S.p.A. (Italy)  

KEY INDUSTRY DEVELOPMENTS

• April 2025: CeriBell, Inc. received FDA approval for its Ceribell Clarity algorithm, which is compatible with an EEG device. The algorithm successfully detects electrographic seizures in pediatric patients.  
• November 2024: Nihon Kohden announced a 71.4% share acquisition of NeuroAdvanced Corp. to enter the epilepsy monitoring market.
• April 2024: Integra LifeSciences Holdings Corporation announced the relaunch of its CereLink ICP monitoring system.
• January 2024: Aditxt, Inc. announced the acquisition of an EEG product portfolio from Brain Scientific, Inc. Through this strategic step, the company is planning to consolidate its position in the neurology monitoring market.
• March 2021: Brain Scientific received FDA approval for its next-generation NeuroCap EEG device. The device has been specifically designed for pediatric use.

REPORT COVERAGE

To gain extensive insights into the market, Download for Customization

Report Scope & Segmentation